Swiss stocks - Factors to watch on May 4
04/05/2026 05:43
ZURICH/GDANSK, May 4 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday: NOVARTIS AG NOVN.S Company received health Canada approval for Fabhalta oral treatment for adults with C3G. ECONOMY Swiss April Manufacturing PMI due at 0730 GMT. SNB sight deposits due at 0800 GMT. (Reporting by Zurich newsroom and Gdansk newsroom) ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com)) For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON: Daily Swiss stock market report in German .SDE All SMI constituent stocks 0#.SSMI DJ STOXX index .STOXX Top 10 STOXX sectors .PGL.STOXXS Top 10 EUROSTOXX sectors .PGL.STOXXES Swiss mid-cap index .SSMI Swiss all-share index .SSHI Swiss market digest .AD.S Sector overview CH/SECTOR1 All Swiss news CH Swiss research news CH-RCH All equity news E SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS
Recent news on Novartis AG
See all newsBrief: Novartis Remind Data At Eaaci Show Rhapsido Potential As First Targeted Therapy For Chronic Inducible Urticaria (Cindu)
Swiss stocks - Factors to watch on June 12
Swiss pharma hub Basel frets over population cap threat
Novartis says rare muscle disease drug shows promise in early trial
Live Markets: Europe at half-time: countdown to the ECB's 'insurance hike'